Amedisys (AMED) Tops Q3 EPS by $0.16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys (AMED) PT Lowered to $200 at Benchmark
October 29, 2021 7:21 AM EDTBenchmark analyst Bill Sutherland lowered the price target on Amedisys (NASDAQ: AMED) to $200.00 (from $235.00) while maintaining a Buy rating.... More



